{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:35:40Z","timestamp":1787866540036,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10815-025-03599-y","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T09:00:36Z","timestamp":1753347636000},"page":"2837-2857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cellular therapies in primary ovarian insufficiency and poor ovarian reserve: a systematic review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5300-5831","authenticated-orcid":false,"given":"Burakhan","family":"Seyihoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3747-5014","authenticated-orcid":false,"given":"Sude","family":"Gucuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-6115","authenticated-orcid":false,"given":"Alp","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"1","key":"3599_CR1","doi-asserted-by":"publisher","first-page":"e23271","DOI":"10.1016\/j.heliyon.2023.e23271","volume":"10","author":"S Sadeghi","year":"2024","unstructured":"Sadeghi S, Mosaffa N, Huang B, Ramezani Tehrani F. Protective role of stem cells in POI: current status and mechanism of action, a review article. Heliyon. 2024;10(1): e23271.","journal-title":"Heliyon"},{"issue":"6","key":"3599_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/13697137.2024.2423213","volume":"27","author":"P Nick","year":"2024","unstructured":"Nick P, et al. Evidence-based guideline: premature ovarian insufficiency. Climacteric. 2024;27(6):510\u201320.","journal-title":"Climacteric"},{"issue":"7","key":"3599_CR3","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, et al. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","journal-title":"Hum Reprod"},{"issue":"2","key":"3599_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/biom14020242","volume":"14","author":"HK Kim","year":"2024","unstructured":"Kim HK, Kim TJ. Current status and future prospects of stem cell therapy for infertile patients with premature ovarian insufficiency. Biomolecules. 2024;14(2):242.","journal-title":"Biomolecules"},{"key":"3599_CR5","doi-asserted-by":"publisher","first-page":"1165574","DOI":"10.3389\/fendo.2023.1165574","volume":"14","author":"C Guo","year":"2023","unstructured":"Guo C, et al. Mesenchymal stem cells therapy improves ovarian function in premature ovarian failure: a systematic review and meta-analysis based on preclinical studies. Front Endocrinol (Lausanne). 2023;14: 1165574.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3599_CR6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"3599_CR7","first-page":"325","volume":"29","author":"T Fang","year":"2014","unstructured":"Fang T, Ding LJ, Yan GJ, Sun HX, Hu YL. Follicular development following transvaginal injection of autologous adipose-derived mesenchymal stromal cells to ovaries in premature ovarian failure patients. Hum Reprod. 2014;29:325\u2013325.","journal-title":"Hum Reprod"},{"key":"3599_CR8","unstructured":"Gabr, H, Elkheir, WA, El-Gazza, A. Autologous stem cell transplantation in patients with idiopathic premature ovarian failure, in Global Congress on Tissue Engineering, Regenerative & Precision Medicine. 2016, J Tissue Sci Eng: San Antonio, USA."},{"key":"3599_CR9","first-page":"250A","volume":"25","author":"PI Igboeli","year":"2018","unstructured":"Igboeli PI, et al. Rejuvenation of premature ovarian failure with stem cells. Reprod Sci. 2018;25:250A\u2013250A.","journal-title":"Reprod Sci"},{"key":"3599_CR10","unstructured":"Pellicer De N, Castellvi SH, Romeu M, Martinez S,\u00a0 Buigues A, Gomez-Segu\u00ed I, Martinez J, Pellicer A. Bone marrow derived stem cells restore ovarian function and fertility in premature ovarian insufficiency women. Interim report of a randomized trial: mobilization versus ovarian injection, in 36th Virtual Annual Meeting of the European Society of Human Reproduction and Embryology. 2020, Human Reproduction: Virtual meeting."},{"key":"3599_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab130.795","author":"N Singh","year":"2021","unstructured":"Singh N, Dogra Y, Mohanty S, Seth T. P\u2013796 trial of autologous marrow derived stem cell ovarian transplantation (TAMSCOT) in young infertile women with diminished ovarian reserve for ovarian rejuvenation \u2013 HOPE still persists. Hum Reprod. 2021. https:\/\/doi.org\/10.1093\/humrep\/deab130.795.","journal-title":"Hum Reprod"},{"key":"3599_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deac107.731","author":"N Singh","year":"2022","unstructured":"Singh N, Patel G, Dogra Y, Mohanty S, Seth T. P-795\u2003comparison of intra-ovarian platelet rich plasma versus autologous bone marrow derived stem cell instillation in women with diminished ovarian reserve for ovarian rejuvenation. Hum Reprod. 2022. https:\/\/doi.org\/10.1093\/humrep\/deac107.731.","journal-title":"Hum Reprod"},{"issue":"12","key":"3599_CR13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3760\/cma.j.cn101441-20210306-00103","volume":"41","author":"AM Xie-Zhenzhen","year":"2021","unstructured":"Xie-Zhenzhen AM, Rufei H, et al. Study on the effect of autologous bone marrow nucleated cell transplantation in the treatment of ovarian dysfunction. J Reprod Contracept. 2021;41(12):1086\u201390. https:\/\/doi.org\/10.3760\/cma.j.cn101441-20210306-00103.","journal-title":"J Reprod Contracept"},{"issue":"3","key":"3599_CR14","first-page":"178","volume":"15","author":"S Tinji\u0107","year":"2021","unstructured":"Tinji\u0107 S, et al. Influence of autologous in vitro activation of ovaries by stem cells and growth factors on endocrine and reproductive function of patients with ovarian insufficiency-a clinical trial study. Int J Fertil Steril. 2021;15(3):178\u201388.","journal-title":"Int J Fertil Steril"},{"issue":"Suppl 2","key":"3599_CR15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s13224-022-01682-3","volume":"72","author":"S Tandulwadkar","year":"2022","unstructured":"Tandulwadkar S, Mishra S, Jain H, Mane N. Ray of hope for decreased ovarian reserve: India\u2019s first two spontaneous conceptions after autologous bone marrow-derived stem cells therapy for ovarian rejuvenation. J Obstet Gynaecol India. 2022;72(Suppl 2):458\u201360.","journal-title":"J Obstet Gynaecol India"},{"key":"3599_CR16","first-page":"12","volume":"10","author":"M Edessy","year":"2014","unstructured":"Edessy M, et al. Stem cells transplantation in premature ovarian failure. World J Med Sci. 2014;10:12\u20136.","journal-title":"World J Med Sci"},{"key":"3599_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5530\/ami.2016.1.7","volume":"3","author":"M Edessy","year":"2016","unstructured":"Edessy M, et al. Autologous stem cells therapy, the first baby of idiopathic premature ovarian failure. Acta Medial International. 2016;3:19\u201323.","journal-title":"Acta Medial International"},{"issue":"5","key":"3599_CR18","first-page":"4105","volume":"15","author":"L Chen","year":"2018","unstructured":"Chen L, et al. Effect of stem cell transplantation of premature ovarian failure in animal models and patients: a meta-analysis and case report. Exp Ther Med. 2018;15(5):4105\u201318.","journal-title":"Exp Ther Med"},{"issue":"3","key":"3599_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.fertnstert.2018.04.025","volume":"110","author":"S Herraiz","year":"2018","unstructured":"Herraiz S, et al. Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders. Fertil Steril. 2018;110(3):496\u2013505.e1.","journal-title":"Fertil Steril"},{"issue":"3","key":"3599_CR20","first-page":"424","volume":"28","author":"N Saharkhiz","year":"2024","unstructured":"Saharkhiz N, Hajizadeh N, Alkhafaji JS, Mohammadi MH. Evaluation of the therapeutic effect of very small stem cells from peripheral blood on the treatment of premature ovarian failure: a pilot study. JBRA Assist Reprod. 2024;28(3):424\u20139.","journal-title":"JBRA Assist Reprod"},{"issue":"12","key":"3599_CR21","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s11427-017-9272-2","volume":"61","author":"L Ding","year":"2018","unstructured":"Ding L, et al. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci. 2018;61(12):1554\u201365.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"3599_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13256-020-02426-5","volume":"14","author":"P Igboeli","year":"2020","unstructured":"Igboeli P, et al. Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature. J Med Case Rep. 2020;14(1): 108.","journal-title":"J Med Case Rep"},{"issue":"2","key":"3599_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/jhrs.JHRS_57_18","volume":"11","author":"S Gupta","year":"2018","unstructured":"Gupta S, Lodha P, Karthick MS, Tandulwadkar SR. Role of autologous bone marrow-derived stem cell therapy for follicular recruitment in premature ovarian insufficiency: review of literature and a case report of world\u2019s first baby with ovarian autologous stem cell therapy in a perimenopausal woman of age 45 year. J Hum Reprod Sci. 2018;11(2):125\u201330.","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"3599_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/jhrs.JHRS_130_19","volume":"13","author":"S Tandulwadkar","year":"2020","unstructured":"Tandulwadkar S, Karthick MS. Combined use of autologous bone marrow-derived stem cells and platelet-rich plasma for ovarian rejuvenation in poor responders. J Hum Reprod Sci. 2020;13(3):184\u201390.","journal-title":"J Hum Reprod Sci"},{"issue":"12","key":"3599_CR25","doi-asserted-by":"publisher","first-page":"e12938","DOI":"10.1111\/cpr.12938","volume":"53","author":"L Yan","year":"2020","unstructured":"Yan L, et al. Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency. Cell Prolif. 2020;53(12): e12938.","journal-title":"Cell Prolif"},{"issue":"4","key":"3599_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s12015-020-09969-6","volume":"16","author":"S Zafardoust","year":"2020","unstructured":"Zafardoust S, et al. Improvement of pregnancy rate and live birth rate in poor ovarian responders by intraovarian administration of autologous menstrual blood derived- mesenchymal stromal cells: phase I\/II clinical trial. Stem Cell Rev Rep. 2020;16(4):755\u201363.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"3599_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13287-023-03568-1","volume":"14","author":"S Zafardoust","year":"2023","unstructured":"Zafardoust S, et al. The effects of intraovarian injection of autologous menstrual blood-derived mesenchymal stromal cells on pregnancy outcomes in women with poor ovarian response. Stem Cell Res Ther. 2023a;14(1):332.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3599_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.arcmed.2022.12.015","volume":"54","author":"S Zafardoust","year":"2023","unstructured":"Zafardoust S, et al. Intraovarian administration of autologous menstrual blood derived-mesenchymal stromal cells in women with premature ovarian failure. Arch Med Res. 2023b;54(2):135\u201344.","journal-title":"Arch Med Res"},{"issue":"1","key":"3599_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13048-020-00743-3","volume":"14","author":"M Mashayekhi","year":"2021","unstructured":"Mashayekhi M, et al. Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human. J Ovarian Res. 2021;14(1):5.","journal-title":"J Ovarian Res"},{"issue":"2","key":"3599_CR30","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1097\/GRH.0000000000000068","volume":"8","author":"MI Cassim","year":"2023","unstructured":"Cassim MI, Mohamed T, Adam JK, Niesler C, Chikandiwa A. Use of autologous adipose-derived mesenchymal stem cells for ovarian rejuvenation in poor responder IVF patients: a phase 1 randomized placebo-controlled double-blind crossover study. Global Reproductive Health. 2023;8(2): e68.","journal-title":"Global Reproductive Health"},{"issue":"24","key":"3599_CR31","doi-asserted-by":"publisher","first-page":"14553","DOI":"10.18632\/aging.205400","volume":"15","author":"A Buigues","year":"2023","unstructured":"Buigues A, et al. Systemic changes induced by autologous stem cell ovarian transplant in plasma proteome of women with impaired ovarian reserves. Aging (Albany NY). 2023;15(24):14553\u201373.","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"3599_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.18565\/aig.2024.63","volume":"2024","author":"YO Martirosyan","year":"2024","unstructured":"Martirosyan YO, Nazarenko TA, Kadaeva AI, Goryunov KV, Shevtsova YA. Activation of ovarian function in patients with diminished ovarian reserve through administration of extracellular vesicles. Akusherstvo i Ginekologiya (Russian Federation). 2024;2024(6):98\u2013104.","journal-title":"Akusherstvo i Ginekologiya (Russian Federation)"},{"key":"3599_CR33","first-page":"102744","volume":"74","author":"L Weng","year":"2024","unstructured":"Weng L, et al. Safety and efficacy of allogenic human amniotic epithelial cells transplantation via ovarian artery in patients with premature ovarian failure: a single-arm, phase 1 clinical trial. eClinMed. 2024;74: 102744.","journal-title":"eClinMed"},{"issue":"3","key":"3599_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.47102\/annals-acadmedsg.2024227","volume":"54","author":"SRS Sugianto","year":"2025","unstructured":"Sugianto SRS, et al. Premature ovarian insufficiency: when ovaries retire early. Ann Acad Med Singapore. 2025;54(3):178\u201391.","journal-title":"Ann Acad Med Singapore"},{"issue":"8","key":"3599_CR35","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/abbs\/gmz065","volume":"51","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, et al. Immunomodulatory effect of human amniotic epithelial cells on restoration of ovarian function in mice with autoimmune ovarian disease. Acta Biochim Biophys Sin (Shanghai). 2019;51(8):845\u201355.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"3599_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13287-017-0721-0","volume":"8","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, et al. Paracrine effects of human amniotic epithelial cells protect against chemotherapy-induced ovarian damage. Stem Cell Res Ther. 2017;8(1):270.","journal-title":"Stem Cell Res Ther"},{"key":"3599_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021277","author":"Y Su","year":"2023","unstructured":"Su Y, et al. Pretreated mesenchymal stem cells and their secretome: enhanced immunotherapeutic strategies. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24021277.","journal-title":"Int J Mol Sci"},{"key":"3599_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13030586","author":"K Kavaldzhieva","year":"2025","unstructured":"Kavaldzhieva K, Mladenov N, Markova M, Belemezova K. Mesenchymal stem cell secretome: potential applications in human infertility caused by hormonal imbalance, external damage, or immune factors. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13030586.","journal-title":"Biomedicines"},{"issue":"2","key":"3599_CR39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/rmb2.12375","volume":"20","author":"T Sato","year":"2021","unstructured":"Sato T, et al. Follicular development during hormone replacement therapy in patients with premature ovarian insufficiency. Reprod Med Biol. 2021;20(2):234\u201340.","journal-title":"Reprod Med Biol"},{"issue":"12","key":"3599_CR40","doi-asserted-by":"publisher","first-page":"865","DOI":"10.14348\/molcells.2014.0145","volume":"37","author":"J Liu","year":"2014","unstructured":"Liu J, et al. Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats. Mol Cells. 2014;37(12):865\u201372.","journal-title":"Mol Cells"},{"issue":"5","key":"3599_CR41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/1566523220666200928142333","volume":"20","author":"W Jiao","year":"2020","unstructured":"Jiao W, Mi X, Qin Y, Zhao S. Stem cell transplantation improves ovarian function through paracrine mechanisms. Curr Gene Ther. 2020;20(5):347\u201355.","journal-title":"Curr Gene Ther"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03599-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03599-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03599-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:17:19Z","timestamp":1761571039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03599-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3599"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03599-y","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}